NM_001128164.2:c.-160-30320C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001128164.2(ATXN1):​c.-160-30320C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.287 in 152,184 control chromosomes in the GnomAD database, including 7,860 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7860 hom., cov: 33)

Consequence

ATXN1
NM_001128164.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.58

Publications

5 publications found
Variant links:
Genes affected
ATXN1 (HGNC:10548): (ataxin 1) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames. [provided by RefSeq, Nov 2017]
ATXN1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 1
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN1NM_001128164.2 linkc.-160-30320C>T intron_variant Intron 6 of 7 ENST00000436367.6 NP_001121636.1 P54253-1Q96FF1
ATXN1NM_000332.4 linkc.-160-30320C>T intron_variant Intron 7 of 8 NP_000323.2 P54253-1Q96FF1
ATXN1NM_001357857.2 linkc.-189-30320C>T intron_variant Intron 7 of 8 NP_001344786.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN1ENST00000436367.6 linkc.-160-30320C>T intron_variant Intron 6 of 7 1 NM_001128164.2 ENSP00000416360.1 P54253-1
ATXN1ENST00000244769.8 linkc.-160-30320C>T intron_variant Intron 7 of 8 1 ENSP00000244769.3 P54253-1

Frequencies

GnomAD3 genomes
AF:
0.287
AC:
43643
AN:
152066
Hom.:
7864
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0789
Gnomad AMI
AF:
0.496
Gnomad AMR
AF:
0.367
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.0973
Gnomad SAS
AF:
0.237
Gnomad FIN
AF:
0.325
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.402
Gnomad OTH
AF:
0.311
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.287
AC:
43645
AN:
152184
Hom.:
7860
Cov.:
33
AF XY:
0.284
AC XY:
21145
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0789
AC:
3281
AN:
41572
American (AMR)
AF:
0.367
AC:
5607
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1191
AN:
3468
East Asian (EAS)
AF:
0.0971
AC:
502
AN:
5168
South Asian (SAS)
AF:
0.238
AC:
1146
AN:
4824
European-Finnish (FIN)
AF:
0.325
AC:
3448
AN:
10602
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.402
AC:
27283
AN:
67942
Other (OTH)
AF:
0.308
AC:
651
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1451
2901
4352
5802
7253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.351
Hom.:
1604
Bravo
AF:
0.284
Asia WGS
AF:
0.148
AC:
513
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.2
DANN
Benign
0.54
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs179978; hg19: chr6-16359021; API